Department of Family and Community Medicine, University of Kentucky, Lexington, KY, USA.
Department of Statistics, Virginia Tech, Blacksburg, VA, USA.
Nicotine Tob Res. 2022 Mar 26;24(5):728-735. doi: 10.1093/ntr/ntab227.
Cigarette smoking continues to be a major health concern and remains the leading preventable cause of death in the US. Recent efforts have been made to determine the potential health and policy benefits of reducing nicotine in combustible cigarettes. The degree to which changes in blood nicotine relate to measures of the abuse liability of reduced-nicotine cigarettes is unknown. The current study examined the relation between blood nicotine and behavioral economic demand measures of cigarettes differing in nicotine content.
Using a within-subject design, participants smoked a single cigarette during each experimental session. Cigarettes included the participant's usual-brand cigarette and SPECTRUM investigational cigarette differing in nicotine level (mg of nicotine to g of tobacco; 15.8 mg/g, 5.2 mg/g, 2.4 mg/g, 1.3 mg/g, and 0.4 mg/g). During each session, blood was collected at multiple timepoints and behavioral economic demand was assessed. Nonlinear mixed-effects models were used to estimate differences in derived intensity (Q0) and change in elasticity (α).
Measures of blood nicotine decreased in an orderly fashion related to nicotine level and significantly predicted change in elasticity (α), but not derived intensity. No differences in demand parameters between the usual brand and 15.8mg/g cigarettes were observed. However, α was significantly higher (lower valuation) for 0.4mg/g than 15.8mg/g cigarettes.
The lowest nicotine level (0.4mg/g) corresponded with the lowest abuse liability (α) compared to the full-strength control (15.8mg/g), with the 1.3mg/g level also resulting in low abuse liability.
This is the first study examining the relative contributions of nicotine content in cigarettes and blood nicotine levels on the behavioral economic demand abuse liability of cigarettes ranging in nicotine content. Our results suggest blood nicotine and nicotine content both predict behavioral economic demand abuse liability. In addition, our results suggest a nicotine content of 1.3mg/g or lower may be effective at reducing cigarette uptake among first-time (naïve) smokers. Our results largely conform to previous findings suggesting a very low nicotine content cigarette maintains lower abuse liability than full-strength cigarettes.
吸烟仍然是一个主要的健康问题,也是美国可预防死亡的主要原因。最近,人们一直在努力确定降低可燃香烟中尼古丁含量的潜在健康和政策益处。血液尼古丁的变化与降低尼古丁香烟滥用倾向的衡量标准之间的关系尚不清楚。本研究检查了血液尼古丁与尼古丁含量不同的香烟的行为经济需求测量值之间的关系。
使用个体内设计,参与者在每个实验阶段都吸烟一支香烟。香烟包括参与者通常品牌的香烟和 SPECTRUM 研究香烟,尼古丁含量不同(尼古丁与烟草的毫克数;15.8mg/g、5.2mg/g、2.4mg/g、1.3mg/g 和 0.4mg/g)。在每个阶段,多次采集血液,并评估行为经济学需求。使用非线性混合效应模型估计衍生强度(Q0)和弹性变化(α)的差异。
血液尼古丁的测量值按尼古丁水平的有序方式下降,与弹性变化(α)显著相关,但与衍生强度无关。在通常的品牌和 15.8mg/g 香烟之间没有观察到需求参数的差异。然而,0.4mg/g 的α值明显高于 15.8mg/g 香烟。
与全强度对照(15.8mg/g)相比,最低尼古丁水平(0.4mg/g)对应最低的滥用倾向(α),1.3mg/g 水平也导致低滥用倾向。
这是第一项研究,考察了香烟中的尼古丁含量和血液尼古丁水平对尼古丁含量不同的香烟的行为经济学需求滥用倾向的相对贡献。我们的结果表明,血液尼古丁和尼古丁含量都可以预测行为经济学需求的滥用倾向。此外,我们的结果表明,尼古丁含量为 1.3mg/g 或更低可能有效降低首次(新手)吸烟者的香烟使用率。我们的结果在很大程度上符合先前的发现,即极低尼古丁含量的香烟比全强度香烟具有更低的滥用倾向。